Skip to main content

Table 1 Antimicrobial susceptibility of B.melitensis

From: In vitro antimicrobial susceptibility testing of human Brucella melitensis isolates from Qatar between 2014 – 2015

  Range (mg/L) MIC50 (mg/L) MIC90 (mg/L) Breakpoints for susceptibility (mg/L)
Doxycycline 0.032–1 0.125 0.25 ≤1 [7]
Tetracycline 0.032–0.5 0.125 0.25 ≤ 1 [7]
Gentamicin 0.064–2 0.25 0.5 ≤ 4 [7]
Streptomycin 0.125–4 0.5 2 ≤ 8 [7]
Trimethoprim-Sulfamethoxazole 0.008–2 0.064 0.25 ≤ 2/38 [7]
Rifampicin 0.008–4 1 2 ≤ 1 [8]
Ciprofloxacin 0.064–0.5 0.25 0.5 ≤ 1 [8]